Spence is a member of the Board of Directors of Medix Infusion, Inc. He joined Noro-Moseley Partners (NMP) in 2010 and supports the firm’s investments in healthcare, software and tech-enabled services. He is focused on reviewing investment opportunities and working with portfolio company management teams to develop and execute their strategic plans. Spence also currently serves on the boards of Aunt Bertha, Contessa Health, Envera Health, LogicStream, Pure Life Renal and Trilliant Health and as a board observer for GetInsured and NovuHealth. Spence previously was on the boards of Change Healthcare (acquired by Emdeon) and Hospicelink (acquired by StateServ Medical/Blue Wolf Capital), and he worked on the firm’s successful investments in Acumen Brands and Wellcentive.

Prior to joining NMP, Spence worked in the corporate development group of Healthways, Inc., where he was responsible for identifying, evaluating and executing acquisitions and strategic partnerships for the company. In addition, he developed numerous business plans on potential new markets, channels and business models for the company’s solutions. Spence was also an associate with the private equity firm Willis Stein & Partners and worked in the investment banking groups of J.C. Bradford and DLJ. Spence is a past chairman of Venture Atlanta and on the Board of Directors of the Southern Capital Forum. He received a BA from Vanderbilt University, where he was a member of Phi Beta Kappa, and an MBA with distinction from the Kellogg School of Management at Northwestern University.